Fundraising Fox

AMD Ventures2025 Investments

5 investments dated 2025 · listed companies and verified rows first · show all

Coherecohere.comin𝕏Sep 2025

Cohere builds foundational AI models and enterprise solutions that help businesses automate tasks, accelerate workflows, and enhance decision-making.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSToronto, CA

Aidan Gomez(Co-founder & CEO)Ivan Zhang(Co-founder)Nick Frosst(Co-founder)in

Co-investorsAdvaita CapitalAju IB Invesment CorporationAlumni VenturesBasecamp FundIndex VenturesInovia Capital+15 more

Coherecohere.ioin𝕏Sep 2025acquired by Ramp

Cohere develops customer engagement software that guides users visually on their screens during support and sales interactions, including over voice and text channels like phone or chat.

AI & Machine LearningEnterprise SoftwareSaaSNew York City, US

Yunyu Lin(Founder)inRahul Sengottuvelu(Founder)in

Co-investorsInovia CapitalRadical VenturesSalesforce VenturesY CombinatorNexxus CapitalNVIDIA+1 more

Liquid AIliquid.aiin𝕏Dec 2025 · $250M

Liquid AI builds device-native foundation models (LFMs) designed to run efficiently on processors outside data centers, such as phones, laptops, and cars, under latency, privacy, and hardware constraints.

AI & Machine LearningDeep TechEnterprise SoftwareBrookline, US

Daniela Rus(Co-founder)Mathias Lechner(Co-founder & CTO)inRamin Hasani(Co-founder & CEO)inAlexander Amini(Co-founder & CSO)Louis Hunt(Executive Officer)Stephen Pagliuca(Director)

Co-investorsBold Capital PartnersDuke Capital PartnersGlasswing VenturesIsaiISAI GestionLink Ventures+4 more

Seekr TechnologiesJun 2025 · $100M

Reston, US

Patrick Condo(Executive Officer, Director)Matthew Jones(Executive Officer)Doug Dubiel(Executive Officer, Director)Robin Clark(Executive Officer, Director)Roger Harris(Director)Marvin Igelman(Director)

Co-investorsDanu Ventures

Somitesomite.aiin𝕏Aug 2025

Cellular Intelligence is a cell therapy company developing engineered cell treatments for diseases, including a Phase 2-ready therapy for Parkinson's disease acquired from Novo Nordisk.

AI & Machine LearningBiotechDeep TechBoston, US

Micha Breakstone, Ph.D.(CEO & co-founder)Allon Klein, Ph.D.(Scientific Co-founder)Olivier Pourquié, Ph.D.(Scientific Co-founder)Cliff Tabin, Ph.D.(Scientific Co-founder)Jay Shendure, M.D., Ph.D.(Scientific Co-founder)Micah Breakstone(Executive Officer, Director, Promoter)

Co-investorsKhosla VenturesNext Coast VenturesSamsung NextFusionLerer HippeauMontage Ventures+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.